• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管生成与眼科疾病

Angiogenesis and ophthalmic disease.

作者信息

Adamis A P, Aiello L P, D'Amato R A

机构信息

Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.

出版信息

Angiogenesis. 1999;3(1):9-14. doi: 10.1023/a:1009071601454.

DOI:10.1023/a:1009071601454
PMID:14517440
Abstract

Ocular angiogenesis is responsible for the majority of irreversible blindness in the developed world [1]. This debilitating complication affects all age groups and characterizes such diverse and widespread diseases as trachoma, retinopathy of prematurity, diabetic retinopathy, neovascular glaucoma and age-related macular degeneration. Although numerous relatively rare conditions also exhibit ocular angiogenesis, the aim of this review will be to briefly summarize our current knowledge regarding the clinical and laboratory findings of the most epidemiologically significant diseases. We will also describe current concepts regarding the pathogenesis of ocular angiogenesis. In this review the term 'neovascularization', which is more prevalent in the ophthalmic literature, will be used to describe the development of pathological new vessels and should be considered synonymous with 'angiogenesis'.

摘要

在发达国家,眼部血管生成是导致大多数不可逆失明的原因[1]。这种使人衰弱的并发症影响所有年龄组,并是沙眼、早产儿视网膜病变、糖尿病视网膜病变、新生血管性青光眼和年龄相关性黄斑变性等多种广泛疾病的特征。尽管许多相对罕见的病症也表现出眼部血管生成,但本综述的目的是简要总结我们目前关于最具流行病学意义疾病的临床和实验室研究结果的知识。我们还将描述眼部血管生成发病机制的当前概念。在本综述中,眼科文献中更常用的术语“新生血管形成”将用于描述病理性新血管的形成,应被视为与“血管生成”同义。

相似文献

1
Angiogenesis and ophthalmic disease.血管生成与眼科疾病
Angiogenesis. 1999;3(1):9-14. doi: 10.1023/a:1009071601454.
2
New concepts in pathogenesis and treatment of diabetic retinopathy.糖尿病视网膜病变发病机制与治疗的新概念。
Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2:S438-50. doi: 10.1055/s-2001-18601.
3
Vascular plasticity--the role of the angiopoietins in modulating ocular angiogenesis.血管可塑性——血管生成素在调节眼部血管生成中的作用
Graefes Arch Clin Exp Ophthalmol. 2001 Dec;239(12):972-5. doi: 10.1007/s004170100365.
4
Interleukin-17: The Role for Pathological Angiogenesis in Ocular Neovascular Diseases.白细胞介素-17:在眼部新生血管疾病病理性血管生成中的作用
Tohoku J Exp Med. 2019 Feb;247(2):87-98. doi: 10.1620/tjem.247.87.
5
Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.一种用于治疗渗出性年龄相关性黄斑变性的抗血管内皮生长因子聚乙二醇化适配体(EYE001)的临床前和1A期临床评估
Retina. 2002 Apr;22(2):143-52. doi: 10.1097/00006982-200204000-00002.
6
Animal models of ocular angiogenesis: from development to pathologies.眼部血管生成的动物模型:从发育到病理状态
FASEB J. 2017 Nov;31(11):4665-4681. doi: 10.1096/fj.201700336R. Epub 2017 Jul 24.
7
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases.胎盘生长因子及其在糖尿病视网膜病变和其他眼部新生血管疾病中的潜在作用。
Acta Ophthalmol. 2018 Feb;96(1):e1-e9. doi: 10.1111/aos.13325. Epub 2016 Nov 22.
8
How to overcome retinal neuropathy: the fight against angiogenesis-related blindness.如何克服视网膜神经病变:与血管生成相关的失明的抗争。
Arch Pharm Res. 2010 Oct;33(10):1557-65. doi: 10.1007/s12272-010-1007-6. Epub 2010 Oct 30.
9
Combination therapy for the treatment of ocular neovascularization.用于治疗眼部新生血管形成的联合疗法。
Angiogenesis. 2007;10(2):141-8. doi: 10.1007/s10456-007-9069-x. Epub 2007 Mar 13.
10
Current molecular understanding and future treatment strategies for pathologic ocular neovascularization.病理性眼新生血管的当前分子认识和未来治疗策略。
Curr Mol Med. 2009 Nov;9(8):973-81. doi: 10.2174/156652409789712783.

引用本文的文献

1
Synthesis and Anti-Angiogenic Activity of Novel c(RGDyK) Peptide-Based JH-VII-139-1 Conjugates.新型基于c(RGDyK)肽的JH-VII-139-1缀合物的合成及抗血管生成活性
Pharmaceutics. 2023 Jan 22;15(2):381. doi: 10.3390/pharmaceutics15020381.
2
Sustained therapeutic effect of an anti-inflammatory peptide encapsulated in nanoparticles on ocular vascular leakage in diabetic retinopathy.包裹于纳米颗粒中的抗炎肽对糖尿病性视网膜病变眼部血管渗漏的持续治疗作用
Front Cell Dev Biol. 2022 Dec 16;10:1049678. doi: 10.3389/fcell.2022.1049678. eCollection 2022.
3
Role of glucose metabolism in ocular angiogenesis (Review).
葡萄糖代谢在眼部血管生成中的作用(综述)。
Mol Med Rep. 2022 Dec;26(6). doi: 10.3892/mmr.2022.12880. Epub 2022 Oct 25.
4
Impact of Lipid/Magnesium Hydroxide Hybrid Nanoparticles on the Stability of Vascular Endothelial Growth Factor-Loaded PLGA Microspheres.载血管内皮生长因子 PLGA 微球的脂质/氢氧化镁混合纳米粒对其稳定性的影响。
ACS Appl Mater Interfaces. 2021 Jun 2;13(21):24370-24384. doi: 10.1021/acsami.0c22140. Epub 2021 May 18.
5
Galloyl Carbohydrates with Antiangiogenic Activity Mediated by Capillary Morphogenesis Gene 2 (CMG2) Protein Binding.具有抗血管生成活性的没食子酰碳水化合物通过毛细血管形态发生基因 2 (CMG2) 蛋白结合介导。
J Med Chem. 2019 Apr 25;62(8):3958-3970. doi: 10.1021/acs.jmedchem.8b01988. Epub 2019 Apr 9.
6
Inhibition of VEGF-dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a.通过靶向 CLEC14a 的优化抗体抑制 VEGF 依赖性血管生成和肿瘤血管生成。
Mol Oncol. 2018 Mar;12(3):356-372. doi: 10.1002/1878-0261.12169. Epub 2018 Jan 26.
7
Electroretinographic evaluations of retinal function before, just after, and after intravitreal injections.玻璃体内注射前、注射刚结束时以及注射后对视网膜功能进行视网膜电图评估。
Sci Rep. 2016 Aug 5;6:31104. doi: 10.1038/srep31104.
8
Thrombospondin-1-Based Antiangiogenic Therapy.基于血小板反应蛋白-1的抗血管生成疗法。
J Ocul Pharmacol Ther. 2015 Sep;31(7):366-70. doi: 10.1089/jop.2015.0018. Epub 2015 Jun 3.
9
Mesenchymal stem cells improve healing of the cornea after alkali injury.间充质干细胞可改善碱烧伤后角膜的愈合。
Graefes Arch Clin Exp Ophthalmol. 2015 Jul;253(7):1121-35. doi: 10.1007/s00417-015-3042-y. Epub 2015 May 23.
10
Current perspectives on ranibizumab.雷珠单抗的当前观点
Clin Ophthalmol. 2015 Mar 20;9:533-42. doi: 10.2147/OPTH.S80049. eCollection 2015.